978 related articles for article (PubMed ID: 35615721)
21. Mendelian randomization analyses in ocular disease: a powerful approach to causal inference with human genetic data.
Li J; Li C; Huang Y; Guan P; Huang D; Yu H; Yang X; Liu L
J Transl Med; 2022 Dec; 20(1):621. PubMed ID: 36572895
[TBL] [Abstract][Full Text] [Related]
22. Causal Inference in Cancer Epidemiology: What Is the Role of Mendelian Randomization?
Yarmolinsky J; Wade KH; Richmond RC; Langdon RJ; Bull CJ; Tilling KM; Relton CL; Lewis SJ; Davey Smith G; Martin RM
Cancer Epidemiol Biomarkers Prev; 2018 Sep; 27(9):995-1010. PubMed ID: 29941659
[TBL] [Abstract][Full Text] [Related]
23. Mendelian Randomization as an Approach to Assess Causality Using Observational Data.
Sekula P; Del Greco M F; Pattaro C; Köttgen A
J Am Soc Nephrol; 2016 Nov; 27(11):3253-3265. PubMed ID: 27486138
[TBL] [Abstract][Full Text] [Related]
24. Mendelian randomization: genetic anchors for causal inference in epidemiological studies.
Davey Smith G; Hemani G
Hum Mol Genet; 2014 Sep; 23(R1):R89-98. PubMed ID: 25064373
[TBL] [Abstract][Full Text] [Related]
25. Causal effects of cardiovascular risk factors on onset of major age-related diseases: A time-to-event Mendelian randomization study.
He L; Culminskaya I; Loika Y; Arbeev KG; Bagley O; Duan M; Yashin AI; Kulminski AM
Exp Gerontol; 2018 Jul; 107():74-86. PubMed ID: 28964830
[TBL] [Abstract][Full Text] [Related]
26. [Challenges and factors that influencing causal inference and interpretation, based on Mendelian randomization studies].
Wang YZ; Shen HB
Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Aug; 41(8):1231-1236. PubMed ID: 32867428
[TBL] [Abstract][Full Text] [Related]
27. Mendelian Randomization and Type 2 Diabetes.
Swerdlow DI
Cardiovasc Drugs Ther; 2016 Feb; 30(1):51-7. PubMed ID: 26809778
[TBL] [Abstract][Full Text] [Related]
28. Combining Mendelian randomization with the sibling comparison design.
Sjölander A; Frisell T; Öberg S; Wang Y; Hägg S
Stat Med; 2024 Feb; 43(4):731-755. PubMed ID: 38073579
[TBL] [Abstract][Full Text] [Related]
29. Mendelian randomization as a tool for causal inference in human nutrition and metabolism.
Larsson SC
Curr Opin Lipidol; 2021 Feb; 32(1):1-8. PubMed ID: 33278081
[TBL] [Abstract][Full Text] [Related]
30. Mendelian randomization: causal inference leveraging genetic data.
Chen LG; Tubbs JD; Liu Z; Thach TQ; Sham PC
Psychol Med; 2024 Jun; 54(8):1461-1474. PubMed ID: 38639006
[TBL] [Abstract][Full Text] [Related]
31. Review of mendelian randomization studies on age at natural menopause.
Zhang X; Huangfu Z; Wang S
Front Endocrinol (Lausanne); 2023; 14():1234324. PubMed ID: 37766689
[TBL] [Abstract][Full Text] [Related]
32. A systematic review of Mendelian randomization studies on multiple sclerosis.
Fazia T; Baldrighi GN; Nova A; Bernardinelli L
Eur J Neurosci; 2023 Aug; 58(4):3172-3194. PubMed ID: 37463755
[TBL] [Abstract][Full Text] [Related]
33. Genetic analyses of gynecological disease identify genetic relationships between uterine fibroids and endometrial cancer, and a novel endometrial cancer genetic risk region at the WNT4 1p36.12 locus.
Kho PF; Mortlock S; ; ; Rogers PAW; Nyholt DR; Montgomery GW; Spurdle AB; Glubb DM; O'Mara TA
Hum Genet; 2021 Sep; 140(9):1353-1365. PubMed ID: 34268601
[TBL] [Abstract][Full Text] [Related]
34. Mendelian randomization studies of cancer risk: a literature review.
Pierce BL; Kraft P; Zhang C
Curr Epidemiol Rep; 2018 Jun; 5(2):184-196. PubMed ID: 30034993
[TBL] [Abstract][Full Text] [Related]
35. Systematic review of Mendelian randomization studies on risk of cancer.
Markozannes G; Kanellopoulou A; Dimopoulou O; Kosmidis D; Zhang X; Wang L; Theodoratou E; Gill D; Burgess S; Tsilidis KK
BMC Med; 2022 Feb; 20(1):41. PubMed ID: 35105367
[TBL] [Abstract][Full Text] [Related]
36. Using Mendelian randomization to investigate a possible causal relationship between adiposity and increased bone mineral density at different skeletal sites in children.
Kemp JP; Sayers A; Smith GD; Tobias JH; Evans DM
Int J Epidemiol; 2016 Oct; 45(5):1560-1572. PubMed ID: 27215616
[TBL] [Abstract][Full Text] [Related]
37. Mendelian Randomization Analysis in Observational Epidemiology.
Lee K; Lim CY
J Lipid Atheroscler; 2019 Sep; 8(2):67-77. PubMed ID: 32821701
[TBL] [Abstract][Full Text] [Related]
38. An atlas on risk factors for type 2 diabetes: a wide-angled Mendelian randomisation study.
Yuan S; Larsson SC
Diabetologia; 2020 Nov; 63(11):2359-2371. PubMed ID: 32895727
[TBL] [Abstract][Full Text] [Related]
39. Selecting instruments for Mendelian randomization in the wake of genome-wide association studies.
Swerdlow DI; Kuchenbaecker KB; Shah S; Sofat R; Holmes MV; White J; Mindell JS; Kivimaki M; Brunner EJ; Whittaker JC; Casas JP; Hingorani AD
Int J Epidemiol; 2016 Oct; 45(5):1600-1616. PubMed ID: 27342221
[TBL] [Abstract][Full Text] [Related]
40. The use of Mendelian randomisation to identify causal cancer risk factors: promise and limitations.
Gala H; Tomlinson I
J Pathol; 2020 Apr; 250(5):541-554. PubMed ID: 32154591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
